
### [NCIT:C35823](http://purl.obolibrary.org/obo/NCIT_C35823)
**Label:** Splenic Disorder

**Subclasses:** [NCIT:C7308](http://purl.obolibrary.org/obo/NCIT_C7308) (Splenic Diffuse Large B-Cell Lymphoma), [NCIT:C7307](http://purl.obolibrary.org/obo/NCIT_C7307) (Splenic Follicular Lymphoma), [NCIT:C7309](http://purl.obolibrary.org/obo/NCIT_C7309) (Splenic Burkitt Lymphoma), [NCIT:C48873](http://purl.obolibrary.org/obo/NCIT_C48873) (Splenic Lymphoma), [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C8459](http://purl.obolibrary.org/obo/NCIT_C8459) (Hepatosplenic T-Cell Lymphoma), [NCIT:C7300](http://purl.obolibrary.org/obo/NCIT_C7300) (Splenic Manifestation of Chronic Lymphocytic Leukemia), [NCIT:C7302](http://purl.obolibrary.org/obo/NCIT_C7302) (Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C7401](http://purl.obolibrary.org/obo/NCIT_C7401) (Hairy Cell Leukemia Variant), [NCIT:C7301](http://purl.obolibrary.org/obo/NCIT_C7301) (Splenic Manifestation of Hairy Cell Leukemia), [NCIT:C80309](http://purl.obolibrary.org/obo/NCIT_C80309) (Splenic Diffuse Red Pulp Small B-Cell Lymphoma), [NCIT:C80308](http://purl.obolibrary.org/obo/NCIT_C80308) (Splenic B-Cell Lymphoma/Leukemia, Unclassifiable), [NCIT:C3383](http://purl.obolibrary.org/obo/NCIT_C3383) (Splenic Neoplasm), [NCIT:C7292](http://purl.obolibrary.org/obo/NCIT_C7292) (Malignant Splenic Soft Tissue Neoplasm), [NCIT:C7294](http://purl.obolibrary.org/obo/NCIT_C7294) (Splenic Non-Hodgkin Lymphoma), [NCIT:C4663](http://purl.obolibrary.org/obo/NCIT_C4663) (Splenic Marginal Zone Lymphoma), [NCIT:C4564](http://purl.obolibrary.org/obo/NCIT_C4564) (Splenic Angiosarcoma), [NCIT:C7299](http://purl.obolibrary.org/obo/NCIT_C7299) (Splenic Manifestation of B-Cell Prolymphocytic Leukemia), [NCIT:C5095](http://purl.obolibrary.org/obo/NCIT_C5095) (Recurrent Splenic Marginal Zone Lymphoma), [NCIT:C7296](http://purl.obolibrary.org/obo/NCIT_C7296) (Splenic Manifestation of Leukemia), [NCIT:C5096](http://purl.obolibrary.org/obo/NCIT_C5096) (Refractory Splenic Marginal Zone Lymphoma), [NCIT:C7295](http://purl.obolibrary.org/obo/NCIT_C7295) (Splenic Hodgkin Lymphoma), [NCIT:C8541](http://purl.obolibrary.org/obo/NCIT_C8541) (Splenic Hemangioma), [NCIT:C7298](http://purl.obolibrary.org/obo/NCIT_C7298) (Splenic Manifestation of T-Cell Prolymphocytic Leukemia), [NCIT:C7297](http://purl.obolibrary.org/obo/NCIT_C7297) (Splenic Manifestation of Prolymphocytic Leukemia), [NCIT:C3539](http://purl.obolibrary.org/obo/NCIT_C3539) (Malignant Splenic Neoplasm), [NCIT:C4902](http://purl.obolibrary.org/obo/NCIT_C4902) (Benign Splenic Neoplasm), [NCIT:C35823](http://purl.obolibrary.org/obo/NCIT_C35823) (Splenic Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C35823](http://purl.obolibrary.org/obo/NCIT_C35823) (Splenic Disorder) 98.28%
- [NCIT:C3383](http://purl.obolibrary.org/obo/NCIT_C3383) (Splenic Neoplasm) 96.55%
- [NCIT:C3539](http://purl.obolibrary.org/obo/NCIT_C3539) (Malignant Splenic Neoplasm) 91.38%
- [NCIT:C48873](http://purl.obolibrary.org/obo/NCIT_C48873) (Splenic Lymphoma) 68.97%
- [NCIT:C7294](http://purl.obolibrary.org/obo/NCIT_C7294) (Splenic Non-Hodgkin Lymphoma) 65.52%
- [NCIT:C7296](http://purl.obolibrary.org/obo/NCIT_C7296) (Splenic Manifestation of Leukemia) 63.79%
- [NCIT:C35814](http://purl.obolibrary.org/obo/NCIT_C35814) (Hematopoietic and Lymphoid System Disorder) 56.39%
- [NCIT:C35813](http://purl.obolibrary.org/obo/NCIT_C35813) (Hematopoietic and Lymphoid System Neoplasm) 54.67%
- Thing 52.35%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 51.63%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 51.53%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 51.52%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 49.83%
- [NCIT:C27134](http://purl.obolibrary.org/obo/NCIT_C27134) (Hematopoietic and Lymphoid Cell Neoplasm) 43.42%
- [NCIT:C26323](http://purl.obolibrary.org/obo/NCIT_C26323) (Hematologic and Lymphocytic Disorder) 43.31%


